I am a researcher at the University Psychiatric Clinics in Basel, Switzerland. My primary research interests are substance use disorders, particularly opioid dependence and opioid agonist treatment.
Table of contents
Updated: September 26, 2024
Baltes-Flückiger, L., Wagner, A., Sattler, I., Meyer, M., Tschopp, A., Walter, M., Colledge, F. (2024) How depression and ADHD relate to exercise addiction: A crosssectional study among frequent exercisers. Frontiers in Psychiatry 15:1427514. doi:10.3389/fpsyg.2024.1427514
Azar, P., Schneiderman, H., Barron, H., Wong, J. S. H., Meyer, M., Newman-Azar, D., Narimani, M., Ignaszewski, M. J., Mathew, N., Mullen, R., Krausz, R.M., Maharaj, A. R. (2024) Rapid induction of transdermal buprenorphine to subcutaneous extended-release buprenorphine for the treatment of opioid use disorder. Addiction Science & Clinical Practice 2024(19):50. doi:10.1186/s13722-024-00479-1
Schaub, A-C., Meyer, M., Tschopp, A., Wagner, A., Lang, U.E., Walter, M., Colledge, F., Schmidt, A (2024) Brain alterations in individuals with exercise dependence: A multimodal neuroimaging investigation. Journal of Behavioral Addictions 13 (2) 565–575 doi:10.1556/2006.2024.00028
Mosandl, C.F., Baltes-Flückiger, L., Kronschnabel, J., Meyer, M., Guessoum, A., Herrmann, O., Vogel, M., Walter, M., Pichler, E-M. (2024) Cannabis use and its association with psychopathological symptoms in a Swiss adult population: a cross-sectional analysis. Frontiers in Public Health 12:1356988. doi:10.3389/fpubh.2024.1356988
Thomann, J., Vogt, S.B., Guessoum, A., Meyer, M., Vogel, M., Liechti, M.E., Luethi, D., Duthaler, U. (2024) Development and validation of an LC-MS/MS method for quantifying diamorphine and its major metabolites 6-monoacetylmorphine, morphine, morphine-3-glucuronide, and morphine-6-glucuronide in human plasma. Journal of Chromatography B 1237:124104 doi:10.1016/j.jchromb.2024.124104
Brezan, F., Meyer, M., Vogel, M., Heimer, J., Falcato, L., Montagna, J., Bruggmann, P. (2024) Prolonged diacethylmorphine take-home during COVID-19 pandemic - Results of a retrospective cohort study. Addiction 2024:1-7 doi:10.1111/add.16503
Mayer-Eckardt, L.N., Gnirrs, O., Meyer, M., Roser, K., Dürsteler, K.M., Vogel, M. (2024) Somatic and mental health among older patients in opioid agonist therapy: a cross-sectional geriatric assessment study. Heroin Addiction and Related Clinical Problems 26 (2) 1-11 doi:10.62401/2531-4122-2024-2
Krausz, R.M., Westenberg, J.N., Tai, A.M.Y., Fadakar, H., Seethapathy, V., Mathew, N., Azar, P., Phillips, A., Schütz, C.G., Choi, F., Vogel, M., Cabanis, M., Meyer, M., Jang, K., Ignaszewski, M. (2024) A Call for an Evidence-Based Strategy Against the Overdose Crisis. Canadian Journal of Psychiatry 69(1):5–9 doi:10.1177/07067437231188202
Schwarz, T., Anzenberger, J., Busch, M., Gmel, G., Kraus, L., Krausz, R.M., Labhart, F., Meyer, M., Schaub, M.P., Westenberg, J.N., Uhl, A. (2023) Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland. Drug and Alcohol Dependence 254:111036 doi:10.1016/j.drugalcdep.2023.111036
Meyer, M., Westenberg, J.N., Jang, K.L., Choi, F., Schreiter, F., Mathew, N., King, C., Lang, U.E., Vogel, M., Krausz, R.M. (2023) Shifting drug markets in North America - a global crisis in the making? International Journal of Mental Health Systems 17 (36) 1-7 doi:10.1186/s13033-023-00601-x
Krausz, R.M., Kazemi, A., Choi, F., Schreiter, S., Meyer, M., Cabanis, M. (2023) Online-Strategie gegen die Opioid-Überdosiskrise in Kanada – RAMP eine Plattform zum Risikomanagement für Drogenkonsumenten. Suchtmedizin – Addiction Medicine 25 (5) 286-292
Fadakar, H., Kim, J., Saunders, L.C., Kamel, M.M., Kianpoor, M., Moghadam, A.H., Hayati, D., Ramadhan, N., Maragha, T., Meyer, M., Jang, K., Krausz, R.M. (2023) Suicidality among university students in the Eastern Mediterranean region: A systematic review. PLOS Global Public Health 2023:1-24. doi:10.1371/journal.pgph.0002460
Shams, F., Tai, A.M.Y., Kim, J., Boyd, M., Meyer, M., Kazemi, A., Krausz, R.M. (2023) Adherence to e-health interventions for substance use and the factors influencing it: Systematic Review, meta-analysis, and meta-regression. Digital Health 2023(9):1-17. doi:10.1177/20552076231203876